Faculty, Staff and Student Publications

Publication Date

4-30-2025

Journal

JNCI Cancer Spectrum

DOI

10.1093/jncics/pkaf043

PMID

40238225

PMCID

PMC12097483

PubMedCentral® Posted Date

4-16-2025

PubMedCentral® Full Text Version

Post-print

Abstract

Assessing Medicare payment trends for cervical cancer care is important to mitigate the financial impact on Medicare. This multiyear cross-sectional study included 65 years and older cervical cancer patients in SEER registries diagnosed between 2010 and 2019 who had continuous Part A and B Medicare coverage at least 6 months before diagnosis and at least within the first year of diagnosis and were not enrolled in any Health Maintenance Organization (HMO) in this duration. The main outcomes were trends in total and service-specific mean monthly Medicare payments within the first year of a cervical cancer diagnosis. This study included 2147 cervical cancer patients. The mean Medicare payments increased from $8300 in 2010 to $8520 in 2019, largely driven by a statistically significant increase in outpatient services costs, from $1361 to $2056 (AAPC = 5.45, 95% CI = 1.38 to 9.67, P = .008). These findings highlight the need for policy actions to mitigate cervical-cancer-related financial impact on Medicare.

Keywords

Humans, United States, Female, Uterine Cervical Neoplasms, Medicare, Cross-Sectional Studies, Aged, SEER Program, Health Expenditures, Aged, 80 and over, Ambulatory Care

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.